Background False-positive histological diagnoses have the same consequences of overdiagnosis in terms of unnecessary treatment. The aim of this systematic review is to assess their frequency at needle core biopsy (CB) and/or surgical excision of the breast. Methods PubMed, Embase, Cochrane Library were systematically searched up to 30 October 2015. Eligibility criteria: cross-sectional studies assessing diagnostic accuracy of CB compared with surgical excision; studies assessing reproducibility of pathologists reading the same slides. Outcomes: false-positive rates; Misclassification of Benign as Malignant (MBM) histological diagnosis; K statistic. Independent reviewers extracted data and assessed quality using an adapted QUADAS-2 tool. Results Sixteen studies assessed CB false-positive rates. In 10 studies (41 989 screen-detected lesions), the range of false-positive rates was 0%-7.1%. Twentyseven studies assessed pathologists' reproducibility. Studies with consecutive, random or stratified samples of all the specimens: at CB the MBM range was 0.25%-2.4% (K values 0.83-0.98); at surgical excision, it was 0.67%-1.2% (K values 0.86-0.94). Studies with enriched samples: the MBM range was 1.4%-6.2% (K values 0.57-0.86). Studies of cases selected for second opinion: the MBM range was 0.29%-12.2% (K values 0.48 and 0.50). Conclusions High heterogeneity of the included studies precluded formal pooling estimates. When considering studies of higher sample size or methodological quality, false-positive rates and MBM are around 1%. The impact of false-positive histological diagnoses of breast cancer on unnecessary treatment, as well as that of overdiagnosis, is not negligible and is of importance in clinical practice.
INTRODUCTION
Histopathology is currently the main criterion for cancer diagnosis. Consequently, diagnostic pathology errors, that is, misdiagnosis, may lead to incorrect patient management, including delays or unnecessary treatment. 1 2 Pathological diagnosis errors have been shown to exist for nearly every cancer type, [3] [4] [5] and the effect of these errors on patient outcome is largely unknown. 2 How to measure and reduce misdiagnosis is a theme of current debate. [6] [7] [8] Implementation of population-based cancer screening has made more critical the issue of falsenegative and false-positive diagnoses. In the context of breast cancer (BC), the introduction of mammographic screening and, more recently, of preoperative MRI, has dramatically increased the detection of non-palpable, minimally invasive carcinoma, ductal carcinoma in situ (DCIS) and borderline lesions, which are difficult to diagnose. Published interobserver reproducibility studies have shown low level of agreement among pathologists. [9] [10] [11] [12] [13] Non-palpable breast lesions are generally diagnosed by core biopsy (CB). This technique allows to avoid a number of open breast biopsies, but the assessment of CB may be complicated, because a small amount of tissue is obtained. Yet, accurate and reproducible histopathology assessment of breast lesions is of crucial importance when deciding on optimal management choices, which may or may not include treatment.
Moreover, since early diagnosis markedly increases the number of patients with relatively favourable prognosis, concerns about false-positive histological diagnosis and the potential harm of unnecessary treatments for cancer have grown. False-positive histological diagnoses have the same consequences of overdiagnosis (diagnoses of 'cancers' that would not have harmed the patient during lifetime 14 ), either in screen-detected or in clinically detected BCs.
In order to assess the risk of false-positive histological diagnoses of BC and the reproducibility of histological diagnoses, we systematically reviewed studies reporting data on the frequency of misclassification of BC in women with suspected malignant lesions undergoing needle CB and/or surgical excision.
METHODS

Data sources and searches
We searched on PubMed, Embase and Cochrane Library all from start date up to 30 October 2015 using a combination of mesh terms and free text words (see online supplementary appendix 1). No language restriction was applied. We inspected the reference lists of the retrieved studies and included relevant articles that we were aware of and that were not captured by our search. Articles suggested by the authors were added to the literature base.
Study selection
Included studies ▸ Cross-sectional studies assessing the diagnostic accuracy of histological examination of specimen from CB; the CB (index test) was compared with the histological examination of specimen from surgical excision (reference standard) (group 1 studies). ▸ Studies assessing the agreement among pathologists reading the same CB or surgical excision slides (group 2 studies). Participants were patients with a suspicion of invasive BC or DCIS, screen and clinically detected. We considered studies where cases were: (a) all patients consecutively recruited in a certain period of time, randomly selected or stratified samples for type of lesion; (b) enriched samples where a type of cancer or a type of diagnosis (ie, malignant or borderline) were intentionally over-represented or selected to increase the statistical power, when the method for over selection was clearly reported, (c) studies including only cases selected for second opinions. We excluded studies where the criteria and method of case selection were not reported or when the criteria were the selection of 'typical' or 'atypical' or particularly difficult to interpret or 'the most representative' lesion according to the subjective opinion of the study authors. Outcomes of interest were: Group 1 studies: the percentage of lesions reclassified from malignant to benign or from invasive cancer to DCIS at CB and surgical excision, respectively. Group 2 studies: false-positive misclassification of histological diagnosis, the K statistic.
Data extraction and quality assessment CB, SG, MGL, SM independently selected potentially relevant studies by reading the search hits' titles and abstracts. SM, CB, NS, AP, PA independently assessed for inclusion each full text. CB, SG, MGL, PA extracted data. SM, PA, NS, AP, SB checked the data extraction. Doubts and disagreement were resolved by discussion.
SG, SM, SB independently assessed the methodological quality of the studies. For group 1 studies, we used the QUADAS-2 scale. 15 For group 2 studies, we did not find in the literature any validated checklist specific for this kind of study. Also standards for reporting are lacking in the international literature; a new checklist for quality of reporting was proposed by a group of experts in 2011, not yet validated. 16 So we used a modified checklist adapted from the QUADAS 17 to make it applicable to assess the quality of reliability and agreement studies, in a similar way already done in other systematic reviews. 18 
Data synthesis and analysis
For group 1 studies, we extracted data on the number of patients (or lesions) according to the following definitions: ▸ CB false-positive rate: that is, percentage of histological diagnoses reclassified from any malignant BC (invasive BC or DCIS) at CB to benign at surgical excision; -lesions diagnosed as invasive carcinoma by CB, reclassified as benign tumour by surgical excision; -lesions diagnosed as DCIS by CB, reclassified as benign tumour by surgical excision. ▸ Lesions diagnosed as invasive carcinoma by CB, downgraded to DCIS by surgical excision. We excluded cases for which it was reported that the lesion found at CB or vacuum-assisted biopsy had been completely excised by the preoperative needle biopsy. Cases receiving neo-adjuvant chemotherapy were also excluded.
For group 2 studies, we extracted data on reproducibility of two (or more) readings of the same specimen calculating histological diagnosis misclassification from available data. When the readers were two, we did not consider one reading as reference unless clearly specified by the authors (ie, expert pathologist). When the readers were more than two, we considered as reference the majority diagnosis, or the consensus diagnosis, or second opinion, or expert diagnosis. We calculated misclassification as follows: ▸ Misclassification of Benign lesions as Malignant (MBM):
lesions classified as benign at the reference diagnosis and as malignant (DCIS and invasive) at the first diagnosis, on all lesions (or readings, according to available data). ▸ Misclassification of DCIS as invasive cancers: lesions classified as DCIS at the reference diagnosis and as invasive at first diagnosis, on the total of malignant lesions at reference. ▸ Misclassification of benign lesions as invasive: lesions classified as benign at the reference diagnosis and as invasive at first diagnosis, on the total of benign lesions at reference. ▸ Misclassification of benign lesions as DCIS: lesions classified as benign at the reference diagnosis and as DCIS at first diagnosis, on the total of benign lesions at reference, When the reference was not clearly specified by the authors, we reported the number of discordant diagnoses.
The overall agreement, in terms of Cohen's kappa (K) or as defined by the authors was reported.
We reported results grouping the studies for the following characteristics: Group 1: studies which included (a) only screen-detected lesions; (b) both screen and clinically detected lesions; (c) type of lesions included not specified. Group 2: (a) studies with consecutively recruited samples in a certain period of time, randomly selected or stratified samples for type of lesion; (b) studies with enriched samples, where a type of cancer or a type of diagnosis (ie, malignant or borderline) were intentionally over-represented or selected; (c) studies including only cases selected for second opinions.
For each subgroup, the range of the outcomes results was reported. No meta-analyses were performed because of the high heterogeneity of the studies included.
RESULTS
Results of the bibliographic search
After removing duplicates, a total of 6932 records were identified through databases searches. A total 6828 records were excluded on the basis of titles and abstracts as clearly not relevant. One hundred and four articles were judged potentially relevant and acquired in full text. Seven further studies were suggested by the authors as potentially relevant. Sixty-seven articles were excluded (reasons for exclusion in online supplementary appendix 2). Forty-three studies were finally included (44 articles). 9 13 19-59 Dahlstrom et al and Sutton et al 24 46 reported the results of the same study (figure 1 Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) flow chart). One study was in French, three studies were in Portuguese, all the others in English.
Characteristic of the included studies
In 50 Three studies included both screen and clinically detected lesions. 26 35 52 Three studies did not report this information. 38 49 54 Recruitment ranged from 1990 to 2012. Detailed study characteristics are reported in online supplementary appendix 3. Group 2: studies assessing reproducibility of two or more readings of the same specimen Twenty-seven studies, analysing a total of 13 017 lesions, assessed the reproducibility of two or more readings of the same 42 Elmore et al reported agreement among the initial independent diagnoses of three expert consensus panel members (CPM), and the concordance between 115 pathologists and the consensus-derived reference diagnosis. 56 Recruitment ranged from 1951 to 2014. Detailed study characteristics are reported in online supplementary appendix 3.
Methodological quality of included studies
The overall risk-of-bias assessment for all included studies is reported in online supplementary appendix 4. Group 1: studies comparing CB versus surgical excision Twelve of the 16 studies were judged at low, 2 at unclear risk 29 39 and 2 at high 24 46 48 risk of patients selection bias. Concerning applicability, all the studies included patients who matched the review question. Thirteen out of sixteen studies were judged at low risk of bias for the conduct or interpretation of the index test; 2 studies were judged at high risk 24 46 48 and 1 study was judged at unclear risk. 52 Concerning applicability, there was low risk for all the studies that the index test, its conduct or interpretation differed from the review question. Thirteen out of sixteen studies were judged at unclear risk of bias for what concerns the conduct of interpretation of reference standard; Tse et al 49 and Verkooijen 47 were judged at low risk of bias, Sutton et al, Dahlstrom et al 24 46 and Rakha et al 36 were judged at high risk of bias. Concerning applicability, there was low concern in all the studies that the target condition as defined by the reference standard does not match the review question. Seven out of sixteen studies were judged at low risk of bias 35 36 39 41 49 50 54 for what concern the patients flow, and 9 at high risk of bias. 22 Group 2: studies assessing reproducibility of two or more readings of the same specimen All but one studies with consecutive or random or stratified samples were judged at low risk of cases selection bias; Palli et al 33 was judged at unclear risk for what concern selection of cases because the sample was consecutively recruited for the Swedish series, but it was unclear for the Italian series; all the six studies with enriched samples were judged at high risk of cases selection bias; among the studies with cases selected for a second opinion, six studies were judged at low; 31 37 44 57-59 the other ones at high risk of cases selection bias. Routine clinical data were available for interpretation only in five studies; 13 21 23 31 43 they were not available in three studies; 27 32 33 it was unclear in the other studies. Thirteen out of 27 studies were judged at low risk of bias for what concern independent and blind evaluation of specimens; 3 studies 23 30 31 were judged at high risk and the other ones at unclear risk. All but one study 57 studies were judged at low risk of bias for patients flow. 26 35 52 comparing histological examination at CB versus surgical excision among 325 total screen and clinically detected lesions, it ranged from 0% to 0.41% among three studies 38 49 54 assessing 2499 lesions whose mode of detection was not reported.
Four studies 22 28 36 48 reported data on screen-detected lesions diagnosed as invasive carcinoma by CB, classified as benign tumour by surgical excision (range 0%-0.94%); three studies 28 36 47 reported data on lesions diagnosed as DCIS by CB, classified as benign tumour by surgical excision (0%-2.1%).
Group 2: studies assessing reproducibility of two or more readings of the same specimen
In table 3, results from studies assessing reproducibility of two or more readings of the same specimen are reported.
Among studies with consecutive or random or stratified samples of all the specimens, MBM of histological diagnosis at CB ranged from 0.25% to 2.4% (four studies), the range of K values was 0.83-0.98 (four studies); at surgical excision MBM ranged from 0.67% to 1.2% (three studies), the K value from 0.86 to 0.94 (three studies); at CB and surgical excision it was estimated as 0.90% (one study), the K value as 0.71; when not reporting the type of specimen, MBM ranged from 0% to 4.8% (four studies), the K value from 0.35 to 0.91 (four studies). In the studies reporting also more detailed data, higher level of misclassification of benign lesion as DCIS is observed (range 0%-3.2%) compared with the levels of misclassification of benign lesions as invasive cancers (range 0%-1.04%). Misclassification of DCIS as invasive cancers, when available, ranged from 0% to 10.8%.
Among studies with enriched samples, MBM of histological diagnosis at CB was 4.4% (one study); at CB and surgical excision it was estimated as 6.2% when reporting data for 115 readers and as 4.03% for the 3 CPM (one study); among studies not reporting the type of specimen, MBM ranged from 1.4% to 3.7% (four studies). The K values range was 0.57-0.86 (five studies). More detailed data were reported by Elmore et al:
56 misclassification of benign lesions as invasive cancers at CB and surgical excision was estimated as 0.70% when reporting data for 115 readers and as 0.23% for the 3 CPM; higher values of misclassification of benign lesions as DCIS (9.6% when reporting data for 115 readers and as 6.5% for the 3 CPM) were observed.
Among studies with only cases selected for a second opinion MBM of histological diagnosis at surgical excision was estimated 0.35% (one study); at CB and surgical excision it ranged from 0.93% to 11% (four studies); among studies not reporting the type of specimen MBM ranged from 0.29% to 12.16% (three studies). The K values were 0.48 and 0.50 (two studies).
DISCUSSION
The objective of the review was to assess the frequency of falsepositive histological diagnosis of BC in women undergoing CB and/or surgical excision. We included two groups of studies: (1) 16 studies, involving a total of 44 713 lesions, assessing the accuracy and the false-positive rate of histological examination from CB compared with histological examination from surgical excision; (2) 27 studies, analysing a total of 13 017 lesions, assessing the reproducibility of two or more readings of the same specimen among pathologists.
In studies on screen-detected lesions assessing CB accuracy compared with surgical excision as reference standard, the falsepositive rate ranged from 0% to 7.1%. In studies with consecutive or random or stratified samples of all the specimens assessing the diagnostic reproducibility among pathologists, the MBM of histological diagnoses ranged from 0.25% to 4.8%. Higher levels of misclassifications were observed for DCIS, and among studies with enriched samples or with cases selected for a second opinion.
The major flaws of studies assessing CB accuracy compared with surgical excision concerned the patients flow and the conduct or interpretation of the reference standard results. The major flaws of studies assessing diagnostic reproducibility among pathologists concerned the method of sample selection and the lack of independent blind evaluation of specimens.
The strength of this review relies in the fact that it provides an overview of all the studies assessing the diagnostic misclassification, in screen and clinically detected BCs retrieved by a comprehensive bibliographic search, in a field which is relatively understudied. 61 On the other hand, a limitation is the high heterogeneity of the included studies, which precluded to formally combine their results in order to give an overall estimate of false-positive histological diagnosis and misclassification rates.
Results from the studies assessing the diagnostic accuracy of CB compared with surgical excision, and from the studies assessing the diagnostic reproducibility among pathologists are different. The majority of the studies comparing CB with surgical excision were conducted with consecutive or representative samples taken from routine practice. If, from this point of view, selection bias is unlikely, on the other side for the majority of them it is unclear whether the pathological diagnosis from surgical excision was blind from or only confirmatory of CB. Also, the experimental context of the studies does not completely reflect clinical practice, in which, for example, there maybe access to second opinion. Moreover, the majority of these studies report results based on small samples. Among studies assessing screen-detected lesions, only two studies 36 47 have large sample sizes. Yet results of Rakha et al 36 are not comparing histological diagnosis at CB and surgical excision in a blind way, assessing false-positive CB diagnosis by collecting further several types of data (ie, radiological ultrasound and clinical opinion, number of CB attempts, number of open surgical procedures to reach a final diagnosis). Taking into account sample size and methodological quality, among the studies assessing the false-positive rate of CB for screen-detected lesions, Verkooijen 47 can be considered an informative study reporting a false-positive rate of 1.04%. A false-positive rate of 0.89% could be estimated adding the results of all the other studies, with a small sample size, 22 24 28 39 41 46 48 50 comparing histological diagnosis at CB and surgical excision for screen-detected lesions. Notwithstanding the high heterogeneity of the design of the studies, a similar overall rough estimate of MBM (0.93%) could be obtained adding the results of all the studies assessing the diagnostic reproducibility among pathologists with consecutive or random or stratified or enriched samples of all the specimens of screen-detected lesions. Considering separately the type of specimen assessed, when adding results of MBM of histological diagnosis at CB only, the estimate is 1.05%; it is 0.87%, when adding results from studies on histological diagnosis at surgical excision only.
To our knowledge, no other systematic reviews with this scope have been published so far. We made every effort to identify all the published literature on this topic by performing sensitive and broad bibliographic searches without any language and date restriction and by contacting authors asking for further information when necessary. Nevertheless, publication bias cannot be ruled out, mainly for these types of studies for which the protocol registration is not required.
Based on the evidence of our review, false-positive histological diagnoses increase unnecessary treatment, in either screen or clinically detected BCs. Although the concordance for invasive BC in the results by Elmore 62 was very good with a discordance of 2.3%, and taking into account that it is very difficult to differentiate between atypia and DCIS, in the same study the variability in the interpretation of individual breast biopsy slides suggest that overinterpretation of the pathological findings may contribute to overtreatment. 8 It has been reported that for women having breast biopsy, nearly one in five (18.5%) with a diagnosis of DCIS would have their biopsy specimen interpreted as atypia or benign by the study's reference consensus panel (with the limiting assumptions that the diagnostic features were present on a single slide and no second opinions were obtained). 62 Moreover in epidemiological studies, a great variation was observed in BC detection rate in population with similar incidence rates. Standardised (European population) total detection rate (×100 000), for women aged 50-69 years, at repeat screening test in 2010 ranges from 2.8 to 5 among the regions in North Italy. 63 Similarly, considerable international variation was found in DCIS detection. The age-standardised detection rate for DCIS varied from 1.6 to 0.45 ( per 1000) among 15 screening settings in 12 countries. 64 This variation could not be fully explained by variation in invasive BC incidence or detection rates. One potential cause of such a great difference could be attributed to variability in pathological interpretation. Difficulties in pathological classifications and a poor relationship between morphological features and prognosis cause an appreciable fraction of overdiagnosed cases of BC. 8 Indeed, for example, disagreements in pathological interpretation and classification of intraductal proliferative lesions, as well as in diagnosing microinvasion, could be considered as potential sources of overdiagnosis 8 56 and overtreatment. 65 The false-positive results represent an important harm, with implications for the diagnostic process both for screen and clinically detected lesions. They should be reduced to a minimum, since a diagnosis of a malignant neoplasia implies management decisions and may result in referral to unnecessary and often complex and costly interventions 7 including surgery, radiation or, for false-positive invasive cancers, chemotherapy. In order to better quantify the actual burden of false-positive histological diagnoses, it would be beneficial to conduct studies in which independent reading of slides and consecutive cases or representative samples of cases are analysed. Quality controls of the diagnostic process, including systematic independent reading or second systematic opinion of biopsy samples for borderline lesions of the breast, may reduce the amount of overdiagnosis in asymptomatic populations. Further research is needed to better investigate the implications of these findings for patient management, the causes of the problem and possible remedies.
CONCLUSIONS
When considering studies of higher sample size or methodological quality only, the frequency of histological misclassification of breast benign lesions to malignant lesions in women undergoing core biopsy or surgical excision ranges around 1%, meaning that of 100 positive core biopsies one is false positive and that of 100 surgical open biopsies with any diagnosis one is false positive. The impact of false-positive histological diagnosis on unnecessary treatment, as well as that of overdiagnosis, 66 is not negligible and of importance in clinical practice.
Take home messages
▸ False positive histological diagnoses have the same consequences of overdiagnosis (diagnoses of "cancers" that would not have harmed the patient during lifetime) either in screen or in clinically detected breast cancers, in terms of overtreatment. ▸ The aim of this systematic review is to assess false positive histological diagnoses frequency at needle core-biopsy and/ or surgical excision. ▸ When considering studies of higher sample size or methodological quality, false positive rates and misclassification of benign as malignant histological diagnosis are around 1%. ▸ The impact of false positive histological diagnoses of breast cancer on unnecessary treatment, as well as that of overdiagnosis, is not negligible and is of importance in clinical practice.
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